Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Na+/H+ exchange inhibitors reported by Hoechst

May 22, 1997

Additional GUSTO III data supports efficacy and safety of Retavase

May 21, 1997

Design of bisoprolol CIBIS II study

May 21, 1997

Orion-Yhtyma discloses potent and selective alpha2-adrenoceptor agonists

May 21, 1997

Peptide P-selectin inhibitors described by Centocor

May 20, 1997

BMS describes angiotensin II antagonists

May 20, 1997

Ribi ImmunoChem offers licenses for cardioprotectant

May 19, 1997

Antiproliferative effects of PCA-4230 in vascular smooth muscle cells

May 16, 1997

SmithKline Beechan to market Kissei's tranilast

May 15, 1997

Antiischemic potassium channel activators described by BMS

May 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...